Cardiovascular changes in animal models of metabolic syndrome
- PMID: 23691518
- PMCID: PMC3647579
- DOI: 10.1155/2013/761314
Cardiovascular changes in animal models of metabolic syndrome
Abstract
Metabolic syndrome has been defined as a group of risk factors that directly contribute to the development of cardiovascular disease and/or type 2 diabetes. Insulin resistance seems to have a fundamental role in the genesis of this syndrome. Over the past years to the present day, basic and translational research has used small animal models to explore the pathophysiology of metabolic syndrome and to develop novel therapies that might slow the progression of this prevalent condition. In this paper we discuss the animal models used for the study of metabolic syndrome, with particular focus on cardiovascular changes, since they are the main cause of death associated with the condition in humans.
Figures
Similar articles
-
Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players.Ann N Y Acad Sci. 1999 Nov 18;892:25-44. doi: 10.1111/j.1749-6632.1999.tb07783.x. Ann N Y Acad Sci. 1999. PMID: 10842650 Review.
-
Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.Dan Med J. 2014 Jul;61(7):B4890. Dan Med J. 2014. PMID: 25123125 Review.
-
Gender differences in the metabolic syndrome and their role for cardiovascular disease.Clin Res Cardiol. 2006 Mar;95(3):136-47. doi: 10.1007/s00392-006-0351-5. Epub 2006 Jan 30. Clin Res Cardiol. 2006. PMID: 16598526 Review.
-
New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).Acta Med Indones. 2006 Jul-Sep;38(3):160-6. Acta Med Indones. 2006. PMID: 17119268 Review.
-
Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. the SMART study.Cardiovasc Diabetol. 2011 Nov 21;10:100. doi: 10.1186/1475-2840-10-100. Cardiovasc Diabetol. 2011. PMID: 22098712 Free PMC article.
Cited by
-
Animal models of metabolic syndrome: a review.Nutr Metab (Lond). 2016 Oct 4;13:65. doi: 10.1186/s12986-016-0123-9. eCollection 2016. Nutr Metab (Lond). 2016. PMID: 27708685 Free PMC article. Review.
-
Targeting mitochondrial dynamics by regulating Mfn2 for therapeutic intervention in diabetic cardiomyopathy.Theranostics. 2019 May 31;9(13):3687-3706. doi: 10.7150/thno.33684. eCollection 2019. Theranostics. 2019. PMID: 31281507 Free PMC article.
-
Angiotensin receptor blockade improves cardiac mitochondrial activity in response to an acute glucose load in obese insulin resistant rats.Redox Biol. 2018 Apr;14:371-378. doi: 10.1016/j.redox.2017.10.005. Epub 2017 Oct 7. Redox Biol. 2018. PMID: 29049981 Free PMC article.
-
The Antidiabetic Activities of Neocryptotanshinone: Screened by Molecular Docking and Related to the Modulation of PTP1B.Nutrients. 2022 Jul 24;14(15):3031. doi: 10.3390/nu14153031. Nutrients. 2022. PMID: 35893885 Free PMC article.
-
Effects of spinach nitrate on insulin resistance, endothelial dysfunction markers and inflammation in mice with high-fat and high-fructose consumption.Food Nutr Res. 2016 Sep 9;60:32010. doi: 10.3402/fnr.v60.32010. eCollection 2016. Food Nutr Res. 2016. PMID: 27616738 Free PMC article.
References
-
- Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabetic Medicine. 2006;23(5):469–480. - PubMed
-
- Defina LF, Vega GL, Leonard D, Grundy SM. Fasting glucose, obesity, and metabolic syndrome as predictors of type 2 diabetes: the cooper center longitudinal study. Journal of Investigative Medicine. 2012;60(8):1164–1168. - PubMed
-
- Dekker JM, Girman C, Rhodes T, et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation. 2005;112(5):666–673. - PubMed
-
- Mulè G, Nardi E, Cottone S, et al. Influence of metabolic syndrome on hypertension-related target organ damage. Journal of Internal Medicine. 2005;257(6):503–513. - PubMed
-
- de las Fuentes L, Brown AL, Mathews SJ, et al. Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass. European Heart Journal. 2007;28(5):553–559. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous